MedPath

Prostaglandins Before Caserean Section

Phase 2
Conditions
Intrapartum Hemorrhage
Interventions
Procedure: elective cesarean section
Registration Number
NCT03366259
Lead Sponsor
Kasr El Aini Hospital
Brief Summary

The aim of our study is to assess the value of administration of prostaglandins before cesarean section to reduce the amount of blood loss

Detailed Description

160 full term pregnant patients candidate for elective cesarean section were randomly allocated into 2 groups ,80 patients will receive 200mcg of rectal prostaglandins before cesarean section and 80 patients are used as control receiving placebo

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
160
Inclusion Criteria

pregnant patients full term elective cesarean section

Exclusion Criteria
  • medical disorder with pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group A (Misoprostol group)Misoprostol 200Mcg Tab200 mcg rectal Misoprostol administration before cesarean section
Group A (Misoprostol group)elective cesarean section200 mcg rectal Misoprostol administration before cesarean section
Group B (control group)elective cesarean sectionNo prostaglandins administration before cesarean section
Primary Outcome Measures
NameTimeMethod
amount of intraoperative blood lossduring cesarean section

number of soaked towels

postpartum hemorrhage24 hour after cesarean section

blood loss after cesarean section

Secondary Outcome Measures
NameTimeMethod
fetal condition5 minutes after cesarean section

apgar score

Trial Locations

Locations (1)

Kasr El Ainiy Hospital

🇪🇬

Cairo, Egypt

Kasr El Ainiy Hospital
🇪🇬Cairo, Egypt
© Copyright 2025. All Rights Reserved by MedPath